FDA Inspection
Eurofins Advantar Laboratories, IncEurofins Advantar Laboratories, Inc – FDA Inspection, Mar 5, 2021
Record Details
This FDA Inspection record concerns Eurofins Advantar Laboratories, Inc, with an inspection on March 5, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 5, 2021
- Product Type
- Drugs
View Company Profile
ID · 4c81f24f-1321-4c4e-be89-e2be0585c02b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1137067
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Eurofins Advantar Laboratories, Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eurofins Advantar Laboratories, Inc
- FDA Inspection 960010 - 2016-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.